Cargando…

Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery

Background: Trimethylamine-N-oxide (TMAO) is formed in the liver from trimethylamine (TMA), a product exclusively generated by the gut microbiota from dietary phosphatidylcholine and carnitine. An alternative pathway of TMAO formation from carnitine is via the microbiota-dependent intermediate γ-but...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trøseid, Marius, Hov, Johannes R., Nestvold, Torunn Kristin, Thoresen, Hanne, Berge, Rolf K., Svardal, Asbjørn, Lappegård, Knut Tore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841908/ https://www.ncbi.nlm.nih.gov/pubmed/27081744 http://dx.doi.org/10.1089/met.2015.0120

Ejemplares similares

Plasma Lipopolysaccharide Is Closely Associated With Glycemic Control and Abdominal Obesity: Evidence from bariatric surgery
por: Trøseid, Marius, et al.
Publicado: (2013)

Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection
por: Haissman, Judith M., et al.
Publicado: (2017)

A Phospholipid-Protein Complex from Antarctic Krill Reduced Plasma Homocysteine Levels and Increased Plasma Trimethylamine-N-Oxide (TMAO) and Carnitine Levels in Male Wistar Rats
por: Bjørndal, Bodil, et al.
Publicado: (2015)

Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial
por: Awoyemi, Ayodeji, et al.
Publicado: (2021)

Low fibre intake is associated with gut microbiota alterations in chronic heart failure
por: Mayerhofer, Cristiane C.K., et al.
Publicado: (2020)

Modulation of Endothelial Function by TMAO, a Gut Microbiota-Derived Metabolite
por: Querio, Giulia, et al.
Publicado: (2023)

Design of the GutHeart—targeting gut microbiota to treat heart failure—trial: a Phase II, randomized clinical trial
por: Mayerhofer, Cristiane C.K., et al.
Publicado: (2018)

Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine-N-Oxide
por: Romano, Kymberleigh A., et al.
Publicado: (2015)

LDL binding to cell receptors and extracellular matrix is proatherogenic in obesity but improves after bariatric surgery
por: Jayaraman, Shobini, et al.
Publicado: (2023)

Association Between Frailty and Gut Microbiota Metabolite TMAO in Older People With Cardiovascular Disease
por: He, Wei, et al.
Publicado: (2020)

Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure
por: Nendl, Andraž, et al.
Publicado: (2023)

Sex Differences in Proatherogenic Cytokine Levels
por: Bernardi, Stella, et al.
Publicado: (2020)

HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammation
por: Hove-Skovsgaard, Malene, et al.
Publicado: (2017)

Rosuvastatin alters the genetic composition of the human gut microbiome
por: Kummen, Martin, et al.
Publicado: (2020)

Oxidized Phospholipids are Proinflammatory and Proatherogenic in Hypercholesterolemic Mice
por: Que, Xuchu, et al.
Publicado: (2018)

Brief Report: Proatherogenic Cytokine Microenvironment in the Aortic Adventitia of Patients With Rheumatoid Arthritis
por: Ahmed, Ammad, et al.
Publicado: (2016)

Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota
por: Chen, Ming-liang, et al.
Publicado: (2016)

Tetradecylthioacetic Acid Increases Hepatic Mitochondrial β-Oxidation and Alters Fatty Acid Composition in a Mouse Model of Chronic Inflammation
por: Burri, Lena, et al.
Publicado: (2011)

Development of post-pericardiotomy syndrome is preceded by an increase in pro-inflammatory and a decrease in anti-inflammatory serological markers
por: Snefjellå, Nora, et al.
Publicado: (2012)

Remote Monitoring of CIEDs—For Both Safety, Economy and Convenience?
por: Lappegård, Knut Tore, et al.
Publicado: (2021)

A fish protein hydrolysate alters fatty acid composition in liver and adipose tissue and increases plasma carnitine levels in a mouse model of chronic inflammation
por: Bjørndal, Bodil, et al.
Publicado: (2013)

Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency
por: Macpherson, Magnhild E., et al.
Publicado: (2020)

Gut Microbiota Dysbiosis and Increased Plasma LPS and TMAO Levels in Patients With Preeclampsia
por: Wang, Jing, et al.
Publicado: (2019)

Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice
por: Zhang, Wenchao, et al.
Publicado: (2021)

Gut Metabolite TMAO Induces Synaptic Plasticity Deficits by Promoting Endoplasmic Reticulum Stress
por: Govindarajulu, Manoj, et al.
Publicado: (2020)

The associations between TMAO-related metabolites and blood lipids and the potential impact of rosuvastatin therapy
por: Xiong, Xiaowei, et al.
Publicado: (2022)

A fatty acid analogue targeting mitochondria exerts a plasma triacylglycerol lowering effect in rats with impaired carnitine biosynthesis
por: Lindquist, Carine, et al.
Publicado: (2018)

Associations between fatty acid oxidation, hepatic mitochondrial function, and plasma acylcarnitine levels in mice
por: Bjørndal, Bodil, et al.
Publicado: (2018)

Background Diet Influences TMAO Concentrations Associated with Red Meat Intake without Influencing Apparent Hepatic TMAO-Related Activity in a Porcine Model
por: Thøgersen, Rebekka, et al.
Publicado: (2020)

Oxidation of Hemoglobin Drives a Proatherogenic Polarization of Macrophages in Human Atherosclerosis
por: Potor, László, et al.
Publicado: (2021)

miR-223 Exerts Translational Control of Proatherogenic Genes in Macrophages
por: Nguyen, My-Anh, et al.
Publicado: (2022)

Gut microbiota and acute coronary syndromes: ready for use in the emergency room?
por: Trøseid, Marius
Publicado: (2017)

Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?
por: Canyelles, Marina, et al.
Publicado: (2023)

The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions
por: Trøseid, Marius, et al.
Publicado: (2020)

Pacemaker implantation in small hospitals: complication rates comparable to larger centres
por: Haug, Bjørn, et al.
Publicado: (2011)

Divergent Effects of Glycemic Control and Bariatric Surgery on Circulating Concentrations of TMAO in Newly Diagnosed T2D Patients and Morbidly Obese
por: Canyelles, Marina, et al.
Publicado: (2022)

Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD)
por: Amrein, Melissa, et al.
Publicado: (2022)

The impact of dapagliflozin on glucose excursions related to early proatherogenic derangement in the aortic wall()
por: Stelmaszyk, Agnieszka, et al.
Publicado: (2018)

A salmon peptide diet alleviates experimental colitis as compared with fish oil
por: Grimstad, Tore, et al.
Publicado: (2013)

Integrated Analysis Reveals the Gut Microbial Metabolite TMAO Promotes Inflammatory Hepatocellular Carcinoma by Upregulating POSTN
por: Wu, Yonglin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tbul4pnehpflv49cgutdc08hck